Fante already fronts the company's commercial operations in North America. He will now also take on Central and South American responsibilities.
"Rich is a strong leader who will enable our company to successfully navigate the challenges facing our industry while delivering innovation and value to our customers, patients and shareholders," said Tony Zook, executive VP, global commercial operations.
in-Pharmatechnologist.com takes a look at the People on the Move this week.
The WHO Executive Board prepares for a special Ebola meeting, CEO leaves troubled biotech, and senior staff...
Novartis's CEO becomes President of EFPIA, a new head of R&D for Genentech, and more People on...